US Patent Issued to BioVentures on April 8 for "Mi-2Beta inhibitor as an immunotherapy agent" (American, Chinese Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,674, issued on April 8, was assigned to BioVentures LLC (Little Rock, Ark.).

"Mi-2Beta inhibitor as an immunotherapy agent" was invented by Hong-yu Li (Little Rock, Ark.), Zhengyu Wang (Little Rock, Ark.), Jingwei Shao (Little Rock, Ark.) and Rutao Cui (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Mi-2Beta inhibitors and methods of using the same are disclosed. The methods comprise administering an effective amount of a Mi-2Beta inhibitor to the subject or contacting a cancer cell or a tumor with an effective amount of a Mi-2Beta inhibitor."

The patent was filed on March 16, 2022, under Application No. 17/696,610.

*For further in...